1 option
Mistakes we make in headache trials / Hans-Christoph Diener.
- Format:
- Video
- Author/Creator:
- Diener, H.-C. (Hans-Christoph), 1951- Speaker.
- Series:
- Henry Stewart talks. Biomedical & life sciences collection. Toward a deeper understanding of headache and migraine.
- Toward a deeper understanding of headache and migraine, 2056-452X
- Language:
- English
- Subjects (All):
- Clinical trials.
- Drugs--Side effects.
- Drugs.
- Headache clinics.
- Headache--Chemotherapy.
- Headache.
- Migraine--Chemotherapy.
- Migraine.
- Migraine--Prevention.
- Calcitonin Gene-Related Peptide Receptor Antagonists.
- Clinical Trials as Topic.
- Drug Development.
- Headache Disorders, Primary--drug therapy.
- Headache Disorders, Secondary--drug therapy.
- Migraine Disorders--drug therapy.
- Serotonin Receptor Agonists.
- Sumatriptan.
- Topiramate.
- zolmitriptan.
- Medical Subjects:
- Calcitonin Gene-Related Peptide Receptor Antagonists.
- Clinical Trials as Topic.
- Drug Development.
- Headache Disorders, Primary--drug therapy.
- Headache Disorders, Secondary--drug therapy.
- Migraine Disorders--drug therapy.
- Serotonin Receptor Agonists.
- Sumatriptan.
- Topiramate.
- zolmitriptan.
- Physical Description:
- 1 videorecording (31 min., 18 sec.) : sound, color.
- Place of Publication:
- London : Henry Stewart Talks, 2023.
- System Details:
- video file
- Contents:
- Contents: Sumatriptan
- Migraine prevention and treatment
- Clinical trial design
- Serotonin receptor agonists
- Therapeutic drug development
- Medication Overuse Headache (MOH)
- Zolmitriptan
- Placebo
- Topiramate
- CGRP receptor antagonists.
- Notes:
- Description based on publisher supplied metadata and other sources.
- Animated audio-visual presentation with synchronized narration.
- Title from title frames.
- Publisher Number:
- 6116 Henry Stewart Talks
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.